Comparison of With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis
Studies reported that Serenoa repens was effective in relieving lower urinary tract symptoms (LUTS). This article carried out a systematic review and meta-analysis to compare Serenoa repens with tamsulosin in the treatment of benign prostatic hyperplasia (BPH) after at least 6-month treatment cycle....
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-04-01
|
Series: | American Journal of Men's Health |
Online Access: | https://doi.org/10.1177/1557988320905407 |
id |
doaj-fd54a8fb4b224e18bde3dd71e303fe03 |
---|---|
record_format |
Article |
spelling |
doaj-fd54a8fb4b224e18bde3dd71e303fe032020-11-25T03:23:47ZengSAGE PublishingAmerican Journal of Men's Health1557-98912020-04-011410.1177/1557988320905407Comparison of With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-AnalysisTong Cai0Yuanshan Cui1Shaoxia Yu2Qian Li3Zhongbao Zhou4Zhenli Gao5Tong Cai, Yuanshan Cui, and Shaoxia Yu contributed equally to this work as co-first authorTong Cai, Yuanshan Cui, and Shaoxia Yu contributed equally to this work as co-first authorTong Cai, Yuanshan Cui, and Shaoxia Yu contributed equally to this work as co-first authorDepartment of Research, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong, ChinaDepartment of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong, ChinaDepartment of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong, ChinaStudies reported that Serenoa repens was effective in relieving lower urinary tract symptoms (LUTS). This article carried out a systematic review and meta-analysis to compare Serenoa repens with tamsulosin in the treatment of benign prostatic hyperplasia (BPH) after at least 6-month treatment cycle. Four studies involving 1,080 patients (543 in the Serenoa repens group and 537 in the tamsulosin group) were included in the meta-analysis. The results were as follows: compared with tamsulosin, Serenoa repens had a same effect in treating BPH in terms of International Prostate Symptom Score (IPSS) (mean difference [MD] 0.63, 95% confidence interval [CI] [−0.33, 1.59], p = 0.20), quality of life (QoL) (MD 1.51, 95% CI [−1.51, 4.52], p = 0.33), maximum flow rate (Qmax) (MD 0.27, 95% CI [−0.15, 0.68], p = 0.21), postvoid residual volume (PVR) (MD −4.23, 95% CI [−22.97, 14.44], p = 0.65), prostate-specific antigen (PSA) (MD 0.46, 95% CI [−0.06, 0.97], p = 0.08) with the exception of prostate volume (PV) (MD −0.29, 95% CI [−0.41, −0.17], p < 0.00001). For side effects, Serenoa repens was well tolerated compared with tamsulosin especially in ejaculation disorders (odds ratio [OR] = 12.56, 95% CI [3.83, 41.18], p < 0.0001) and decreased libido (OR = 5.40; 95% CI [1.17, 24.87]; p = 0.03). This study indicated that Serenoa repens had the same effect in treating BPH compared with tamsulosin in terms of IPSS, QoL, and PVR after at least 6-month treatment cycle, however, the latter had a greater improvement in PV compared with the former. And Serenoa repens did not increase the risk of adverse events especially with respect to ejaculation disorders and libido decrease.https://doi.org/10.1177/1557988320905407 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Tong Cai Yuanshan Cui Shaoxia Yu Qian Li Zhongbao Zhou Zhenli Gao |
spellingShingle |
Tong Cai Yuanshan Cui Shaoxia Yu Qian Li Zhongbao Zhou Zhenli Gao Comparison of With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis American Journal of Men's Health |
author_facet |
Tong Cai Yuanshan Cui Shaoxia Yu Qian Li Zhongbao Zhou Zhenli Gao |
author_sort |
Tong Cai |
title |
Comparison of With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis |
title_short |
Comparison of With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis |
title_full |
Comparison of With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis |
title_fullStr |
Comparison of With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis |
title_full_unstemmed |
Comparison of With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis |
title_sort |
comparison of with tamsulosin in the treatment of benign prostatic hyperplasia: a systematic review and meta-analysis |
publisher |
SAGE Publishing |
series |
American Journal of Men's Health |
issn |
1557-9891 |
publishDate |
2020-04-01 |
description |
Studies reported that Serenoa repens was effective in relieving lower urinary tract symptoms (LUTS). This article carried out a systematic review and meta-analysis to compare Serenoa repens with tamsulosin in the treatment of benign prostatic hyperplasia (BPH) after at least 6-month treatment cycle. Four studies involving 1,080 patients (543 in the Serenoa repens group and 537 in the tamsulosin group) were included in the meta-analysis. The results were as follows: compared with tamsulosin, Serenoa repens had a same effect in treating BPH in terms of International Prostate Symptom Score (IPSS) (mean difference [MD] 0.63, 95% confidence interval [CI] [−0.33, 1.59], p = 0.20), quality of life (QoL) (MD 1.51, 95% CI [−1.51, 4.52], p = 0.33), maximum flow rate (Qmax) (MD 0.27, 95% CI [−0.15, 0.68], p = 0.21), postvoid residual volume (PVR) (MD −4.23, 95% CI [−22.97, 14.44], p = 0.65), prostate-specific antigen (PSA) (MD 0.46, 95% CI [−0.06, 0.97], p = 0.08) with the exception of prostate volume (PV) (MD −0.29, 95% CI [−0.41, −0.17], p < 0.00001). For side effects, Serenoa repens was well tolerated compared with tamsulosin especially in ejaculation disorders (odds ratio [OR] = 12.56, 95% CI [3.83, 41.18], p < 0.0001) and decreased libido (OR = 5.40; 95% CI [1.17, 24.87]; p = 0.03). This study indicated that Serenoa repens had the same effect in treating BPH compared with tamsulosin in terms of IPSS, QoL, and PVR after at least 6-month treatment cycle, however, the latter had a greater improvement in PV compared with the former. And Serenoa repens did not increase the risk of adverse events especially with respect to ejaculation disorders and libido decrease. |
url |
https://doi.org/10.1177/1557988320905407 |
work_keys_str_mv |
AT tongcai comparisonofwithtamsulosininthetreatmentofbenignprostatichyperplasiaasystematicreviewandmetaanalysis AT yuanshancui comparisonofwithtamsulosininthetreatmentofbenignprostatichyperplasiaasystematicreviewandmetaanalysis AT shaoxiayu comparisonofwithtamsulosininthetreatmentofbenignprostatichyperplasiaasystematicreviewandmetaanalysis AT qianli comparisonofwithtamsulosininthetreatmentofbenignprostatichyperplasiaasystematicreviewandmetaanalysis AT zhongbaozhou comparisonofwithtamsulosininthetreatmentofbenignprostatichyperplasiaasystematicreviewandmetaanalysis AT zhenligao comparisonofwithtamsulosininthetreatmentofbenignprostatichyperplasiaasystematicreviewandmetaanalysis |
_version_ |
1724604623186034688 |